Related Experiment Videos
Study on hepatic artery chemoembolization using temperature-sensitive liposome or lipiodol emulsion
1Department of Hospital Pharmacy, Toyama Medical and Pharmaceutical University, Japan.
Biological & Pharmaceutical Bulletin
|February 1, 1995
Summary
Novel temperature-sensitive liposomes offer improved hepatic tumor treatment via chemoembolization. This method enhances doxorubicin accumulation and reduces side effects compared to traditional emulsions.
Area of Science:
- Oncology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Hepatic tumors are a significant health concern.
- Current chemoembolization methods have limitations, including side effects and drug release profiles.
Purpose of the Study:
- To evaluate temperature-sensitive liposomes as a novel chemoembolization agent for hepatic tumors.
- To compare the efficacy and safety of liposomal doxorubicin with Lipiodol emulsion.
Main Methods:
- Hepatic artery chemoembolization using temperature-sensitive liposomes (dipalmitoylphosphatidylcholine or Lipiodol emulsions entrapping doxorubicin) in hepatic tumor-bearing rats.
- Administration via cannula into the hepatic artery.
- Comparison with Lipiodol emulsion treatment.
Main Results:
- Liposomal doxorubicin demonstrated enhanced accumulation in tumors with hyperthermia.
- Lipiodol emulsion showed a slower drug release profile.
- Both methods inhibited tumor growth and caused tumor reduction.
- Liposomal chemoembolization significantly reduced liver tissue necrosis and abnormal GPT levels compared to Lipiodol emulsion.
Conclusions:
- Temperature-sensitive liposomes represent a promising novel method for hepatic tumor chemoembolization.
- This approach offers improved drug targeting and a better safety profile than conventional Lipiodol emulsions.
- Further research is warranted to explore the full clinical potential of this liposomal delivery system.